JP2012524070A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524070A5
JP2012524070A5 JP2012505953A JP2012505953A JP2012524070A5 JP 2012524070 A5 JP2012524070 A5 JP 2012524070A5 JP 2012505953 A JP2012505953 A JP 2012505953A JP 2012505953 A JP2012505953 A JP 2012505953A JP 2012524070 A5 JP2012524070 A5 JP 2012524070A5
Authority
JP
Japan
Prior art keywords
group
enyl
dimethyl
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012505953A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524070A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/031363 external-priority patent/WO2010121111A1/en
Publication of JP2012524070A publication Critical patent/JP2012524070A/ja
Publication of JP2012524070A5 publication Critical patent/JP2012524070A5/ja
Pending legal-status Critical Current

Links

JP2012505953A 2009-04-17 2010-04-16 抗接着剤 Pending JP2012524070A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17031609P 2009-04-17 2009-04-17
US61/170,316 2009-04-17
PCT/US2010/031363 WO2010121111A1 (en) 2009-04-17 2010-04-16 Antiadhesion agents

Publications (2)

Publication Number Publication Date
JP2012524070A JP2012524070A (ja) 2012-10-11
JP2012524070A5 true JP2012524070A5 (enExample) 2013-03-28

Family

ID=42981455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012505953A Pending JP2012524070A (ja) 2009-04-17 2010-04-16 抗接着剤

Country Status (6)

Country Link
US (1) US8362071B2 (enExample)
EP (1) EP2418948B1 (enExample)
JP (1) JP2012524070A (enExample)
AU (1) AU2010236323A1 (enExample)
CA (1) CA2759011A1 (enExample)
WO (1) WO2010121111A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2414205T3 (es) 2006-06-02 2013-07-18 The Ohio State University Research Foundation Agentes terapéuticos para el tratamiento de linfoma de células del manto
WO2010120711A1 (en) 2009-04-13 2010-10-21 The Ohio State University Research Foundation Protein phosphatase 2a-activating agents
EP2418948B1 (en) 2009-04-17 2013-09-04 The Ohio State University Research Foundation Antiadhesion agents
WO2012074960A2 (en) 2010-11-29 2012-06-07 The Ohio State University Research Foundation Fty720-derived anticancer agents
US9220706B2 (en) * 2012-06-01 2015-12-29 National Institutes Of Health (Nih) Inhibition of leukemic stem cells by PP2A activating agents
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
DE2822324C3 (de) 1978-05-22 1981-02-26 Basf Ag, 6700 Ludwigshafen Herstellung von Vitamin-E-Trockenpulver
JPS59222415A (ja) 1983-05-31 1984-12-14 Kuraray Co Ltd 免疫調節剤
SK282225B6 (sk) 1995-12-28 2001-12-03 Welfide Corporation Použitie 2-amino-2[2-(4-oktylfenyl)etyl]-propán-1,3-diolu alebo jeho farmaceuticky prijateľnej adičnej soli s kyselinou na výrobu farmaceutického prostriedku
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
JPH1180026A (ja) 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
US6770672B1 (en) 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6703384B2 (en) 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
RU2232758C2 (ru) 1998-09-23 2004-07-20 Рисерч Дивелопмент Фаундейшн Токоферолы, токотриенолы и другие производные хромана и боковых цепей и способы лечения с их использованием
AU2001236805B2 (en) 2000-02-11 2005-07-14 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
CA2455547A1 (en) 2001-07-27 2003-02-13 University Of Rochester Use of vitamin e succinate and antiandrogen combination
US6858227B1 (en) 2001-11-21 2005-02-22 Sonus Pharmaceuticals, Inc. Vitamin E conjugates
US20050215531A1 (en) 2002-05-16 2005-09-29 Thomas Baumruker Use of edg receptor binding agents in cancer
JP4861177B2 (ja) 2003-09-12 2012-01-25 ニューロノバ エービー 神経系の障害の処置
CA2583087C (en) * 2003-09-19 2012-07-10 Galileo Pharmaceuticals, Inc. Chroman derivatives
CN101346346B (zh) 2005-12-15 2012-08-22 田边三菱制药株式会社 胺化合物及其医药用途
US20080009545A1 (en) 2006-02-21 2008-01-10 The Ohio State University Research Foundation Anticancer agents
ES2414205T3 (es) 2006-06-02 2013-07-18 The Ohio State University Research Foundation Agentes terapéuticos para el tratamiento de linfoma de células del manto
CA2660880C (en) 2006-08-17 2015-10-13 Betty C. Soliven Treatment of inflammatory diseases
BRPI0813683A2 (pt) 2007-06-14 2019-09-24 Mitsubishi Tanabe Pharma Corp composto amina e uso farmacêutico do mesmo
WO2010042998A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators
WO2010120711A1 (en) 2009-04-13 2010-10-21 The Ohio State University Research Foundation Protein phosphatase 2a-activating agents
EP2418948B1 (en) 2009-04-17 2013-09-04 The Ohio State University Research Foundation Antiadhesion agents

Similar Documents

Publication Publication Date Title
JP2014515406A5 (enExample)
JP2012531433A5 (enExample)
JP2012524070A5 (enExample)
JP2016514159A5 (enExample)
JP2016501882A5 (enExample)
JP2016503799A5 (enExample)
JP2013507423A5 (enExample)
JP2013508288A5 (enExample)
JP2011509949A5 (enExample)
JP2012144574A5 (enExample)
JP2014508811A5 (enExample)
JP2010527913A5 (enExample)
JP2013542261A5 (enExample)
JP2013510120A5 (enExample)
MY150289A (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
JP2010001302A5 (enExample)
JP2012504133A5 (enExample)
JP2013542992A5 (enExample)
JP2010519270A5 (enExample)
JP2013500256A5 (enExample)
JP2012508249A5 (enExample)
JP2012509265A5 (enExample)
JP2011227454A5 (enExample)
JP2013514980A5 (enExample)
JP2012512863A5 (enExample)